Epi-Oral F199 - systemic anti-age therapy and antioxidant protection: ingredients


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Damage to macromolecules, membranes and other subcellular structures by reactive oxygen species plays an important role in the pathogenesis of aging. Improving antioxidant status through the consumption of dietary antioxidants can prevent the onset of chronic disease and premature aging. Biologically active anti-age oral supplement Epi-Oral F199 - «the secret of youth», contains 7 well-studied antioxidants. Daily intake of a biologically active anti-age supplement of epigenetic orientation Epi-Oral F199 allows to stop the insenescence and premature aging of the body in general and the skin in particular, to protect against aggressive environmental factors and restore the correct functioning of the cell.

全文:

受限制的访问

作者简介

A. Grigorieva

Premierpharm Company

Moscow, Russia

L. Berzegova

Premierpharm Company

Moscow, Russia

K. Kozhina

Premierpharm Company

Moscow, Russia

Elena Svechnikova

Polyclinic № 1 of the Administrative Department of the President of the Russian Federation

Email: elene-elene@bk.ru
Dr. Sci. (Med.), Head of the Department of Dermatovenereology and Cosmetology Moscow, Russia

参考

  1. Урланис Б.Ц. Рождаемость и продолжительность жизни в СССР. М., 1963
  2. Ашапкин В.В. Epi-Oral F199TM - биологически активная anti-aging добавка с поливекторным механизмом действия. Часть 1. Метаморфозы. 2017;20:48-53
  3. Ашапкин В.В. Epi-Oral F199TM - биологически активная anti-aging добавка с поливекторным механизмом действия. Часть 2. Фукоксантин. Метаморфозы. 2018;21:48-54.
  4. Ашапкин В.В. Epi-Oral F199TM - биологически активная anti-aging добавка с поливекторным механизмом действия. Часть 3. Ресвератрол. Метаморфозы. 2018;23:48-51
  5. Ашапкин В.В. Epi-Oral F199™ - биологически активная anti-aging добавка с поливекторным механизмом действия. Часть 4. Лютеин и зеаксантин. Метаморфозы. 2019;27:16-9

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2021